The impact of radiometabolic features on the stage and survival in small cell lung cancer
Annals of Thoracic Medicine · 2026-07 · 21 (3) · 140-146
DOI: 10.4103/atm.atm_87_25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Thoracic Medicine, online erschienen am 03.04.2026. Verfasst von Coskun Dogan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonology, Faculty of Medicine, Istanbul Medeniyet University, Istanbul, Turkey. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: Small-cell lung cancer (SCLC) is a highly aggressive malignancy with a poor prognosis. 18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) plays a critical role in staging, as elevated FDG uptake is associated with tumor aggressiveness and metabolic activity. Although radiometabolic parameters such as maximum standardized uptake value (SUVmax), metabolic tumor volume (MTV), and total lesion glycolysis (TLG) have been proposed as prognostic markers, existing data remain inconsistent. This study aimed to investigate the association between these parameters and disease stage and overall survival (OS) in SCLC patients. METHODS: Patients diagnosed with lung cancer between May 2022 and June 2023 were retrospectively reviewed and divided into two groups: those with SCLC (Group 1) and those with non-SCLC (Group 2). Demographic, clinical, radiological (thoracic CT), and radiometabolic (PET/CT) features, treatment history, staging, and mortality data (based on the national death registry) were collected. RESULTS: A total of 111 patients (mean age: 65.2 years) were included, of whom 65 (58.6%) had SCLC. In the SCLC group, 55 (85.9%) had extensive-stage disease and 9 (14.1%) had limited-stage disease. Mean SUVmax, MTV, and TLG values were significantly higher in extensive-stage disease (12.5, 87.2, and 624.2, respectively) than in limited-stage disease (7.1, 7.0, and 37.0) ( P < 0.05). Median OS was 12.5 months. Cutoff values for poor prognosis were identified as SUVmax ≥10, MTV ≥40, and TLG ≥170, with significantly shorter OS observed above these thresholds ( P < 0.05). While SUVmax alone was not an independent predictor of survival ( P > 0.05), MTV and TLG were identified as significant prognostic indicators in multivariate analysis ( P < 0.05). CONCLUSION: In SCLC, higher SUVmax values are associated with advanced disease stage. However, MTV and TLG may serve as more reliable independent prognostic biomarkers for survival.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pulmonology, Faculty of Medicine, Istanbul Medeniyet University, Istanbul, Turkey.
- Clinic of Chest Diseases, University of Health Sciences, Sancaktepe Sehit Prof. Dr. Ilhan Varank Training and Research Hospital, Istanbul, Turkey.
- Department of Pulmonology, Faculty of Medicine, Koç University, Istanbul, Turkey.
- Department of Pathology, Istanbul Medeniyet University, Göztepe Training and Research Hospital, Istanbul, Turkey.
- Department of Nuclear Medicine, Faculty of Medicine, Istanbul Medeniyet University, Istanbul, Turkey.
- Department of Emergency Medicine, Faculty of Medicine, Istanbul Medeniyet University, Göztepe Training and Research Hospital, Istanbul, Turkey.
Zitieren
APA
Dogan, C., Tok, S. C., Karakaya, S., Parmaksiz, E. T., Karatas, F., Yildirim, A. T., Güngör, S., İncealtın, O., & İçten, S. (2026). The impact of radiometabolic features on the stage and survival in small cell lung cancer. Annals of Thoracic Medicine, 21(3), 140-146. https://doi.org/10.4103/atm.atm_87_25
Vancouver
Dogan C, Tok SC, Karakaya S, Parmaksiz ET, Karatas F, Yildirim AT, et al. The impact of radiometabolic features on the stage and survival in small cell lung cancer. Annals of Thoracic Medicine. 2026;21(3):140-146. doi:10.4103/atm.atm_87_25
BibTeX
@article{Dogan2026,
author = {Dogan, Coskun and Tok, Sedanur Coskun and Karakaya, Sibel and Parmaksiz, Elif Torun and Karatas, Ferhan and Yildirim, Aysenur Toksöz and Güngör, Serkan and İncealtın, Onur and İçten, Sacit},
title = {The impact of radiometabolic features on the stage and survival in small cell lung cancer},
journal = {Annals of Thoracic Medicine},
year = {2026},
volume = {21},
number = {3},
pages = {140--146},
doi = {10.4103/atm.atm_87_25}
}
EUVIMED